Physician profile
Ashley Brooke Fields
NPI 1891050522
$1,042.08
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $390 · 2022: $243 · 2023: $300 · 2024: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $222.87 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $160.85 | 2023-2024 | |
| Amarin Pharma, INC. | $138.68 | 2021 | |
| Lilly USA, LLC | $103.91 | 2021-2023 | Mounjaro |
| Sanofi-Aventis U.S. LLC | $96.46 | 2022 | |
| Janssen Pharmaceuticals, INC | $77.50 | 2023 | Spravato |
| Biohaven Pharmaceuticals, INC. | $52.84 | 2021 | |
| Abbvie INC. | $48.05 | 2021 | |
| Esperion Therapeutics, INC. | $35.15 | 2022 | |
| Gilead Sciences, INC. | $24.95 | 2021 | |
| Viiv Healthcare Company | $22.11 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.80 | 2022 | |
| Sonex Health, INC. | $15.46 | 2023 | Sx-One Microknife |
| Surmodics, INC. | $12.27 | 2022 | |
| Irhythm Technologies, INC. | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.